Free Trial

Coherus Oncology (CHRS) SEC Filings & 10K Form

Coherus Oncology logo
$0.88 -0.02 (-1.67%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$0.90 +0.02 (+2.07%)
As of 07/18/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Coherus Oncology SEC Filings

DateFilerForm TypeView
07/03/2025
3:10 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
5:48 PM
Coherus Oncology (Issuer)
Erbez Georgia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:48 PM
Coherus Oncology (Issuer)
Karachun Rita A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:49 PM
Coherus Oncology (Issuer)
Ryan Michael Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:49 PM
Coherus Oncology (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:50 PM
Coherus Oncology (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:50 PM
Coherus Oncology (Issuer)
O'Donnell-Tormey Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:46 PM
Coherus Oncology (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:47 PM
Coherus Oncology (Issuer)
Newton Charles W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:12 PM
Coherus Oncology (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:58 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:59 PM
Coherus Oncology (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
4:07 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
4:37 PM
Coherus Oncology (Subject)
SATTERFIELD THOMAS A JR (Filed by)
Form SCHEDULE 13G
04/14/2025
7:00 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
3:28 PM
Coherus Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
5:02 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
3:31 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
7:34 AM
Coherus Oncology (Filer)
Form DEFA14A
03/04/2025
7:32 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
4:24 PM
Coherus Oncology (Filer)
Form DEFM14A
01/22/2025
6:48 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:49 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:51 PM
Coherus Oncology (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:21 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:06 PM
Coherus Oncology (Filer)
Form PREM14A
01/13/2025
7:45 PM
Coherus Oncology (Filer)
Form DEFA14A
01/13/2025
3:25 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
7:50 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:51 PM
Coherus Oncology (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:52 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:44 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:21 PM
Coherus Oncology (Filer)
Form DEFA14A
12/03/2024
6:11 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
6:13 AM
Coherus Oncology (Filer)
Form DEFA14A
11/13/2024
3:30 PM
Coherus Oncology (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/06/2024
3:23 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:15 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:39 PM
Coherus Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:47 PM
Coherus Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:23 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Genesis 14:13-17 [HIDDEN MEANING?] (Ad)

A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.

Watch the presentation on America’s hidden birthright
07/24/2024
7:14 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
7:16 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
7:23 AM
Coherus Oncology (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CHRS) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners